Seth Sherman, MD
Sports Medicine · Stanford, CANPI 1013184290
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (33.3%), speaking fees and royalties or licence payments — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Linvatec Corporation at 39.1% of the total. 2025 is the largest year on record at $280,420, 2.2 times the $125,679 reported in 2019. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 813 payments — averaging $1412.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$449K
- Arthrex$229K
- Smith+Nephew$125K
- Vericel Corporation$88K
- DJO, LLC$82K
- Bodycad USA Corp$22K
- plus $152K from 31 others
Across 37 payments — averaging $19,061 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aesculap Biologics, LLC$544K
- Zimmer Biomet$81K
- Miach Orthopaedics, Inc.$73K
- Synthes USA Products LLC$6K
- Sanofi-aventis U.S. LLC$1K
What the payments were for
- Royalty or licence$292,16625%
- Consulting fees$382,19133%
- Speaking & faculty fees$338,79230%
- Travel & lodging$100,0779%
- Food & beverage$22,3662%
- Education$12,6101%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 143 | $449,437 |
| Arthrex | 263 | $229,264 |
| Smith+Nephew | 112 | $124,911 |
| Vericel Corporation | 72 | $88,123 |
| DJO, LLC | 44 | $81,942 |
| Bodycad USA Corp | 13 | $22,429 |
| Bioventus LLC | 18 | $22,073 |
| Kinamed, Inc. | 7 | $16,266 |
| Synthes GmbH | 18 | $15,613 |
| Moximed, Inc | 8 | $13,800 |
| Evolution Surgical, Inc | 27 | $13,298 |
| Joint Restoration Foundation, Inc. | 12 | $12,087 |
| Pacira Pharmaceuticals Incorporated | 5 | $9,225 |
| Sanofi-aventis U.S. LLC | 2 | $8,500 |
| Pacira Therapeutics, Inc. | 8 | $8,462 |
| Conmed Corporation | 3 | $7,379 |
| Biorez, Inc. | 2 | $7,300 |
| Averitas Pharma Inc. | 6 | $4,694 |
| Medical Device Business Services, Inc. | 2 | $3,239 |
| Arcuro Medical Inc | 4 | $2,133 |
| Aesculap Biologics, LLC | 16 | $1,548 |
| Depuy Synthes Products, Inc. | 1 | $1,170 |
| Olympus America Inc. | 1 | $1,170 |
| Ossio Inc | 5 | $958 |
| Brixton Biosciences, Inc. | 1 | $850 |
| Stryker | 5 | $546 |
| Lifenet Health | 1 | $502 |
| Xiros Inc | 3 | $316 |
| Organogenesis Inc. | 1 | $250 |
| Zimmer Biomet | 2 | $218 |
| Abanza Inc. | 2 | $204 |
| Lightbody Medical Technologies Inc | 1 | $102 |
| Medtronic | 1 | $79 |
| RTI Surgical, Inc | 1 | $45 |
| Overture Orthopaedics | 1 | $31 |
| Abbott | 1 | $23 |
| Cartiheal (2009) LTD. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY KNEE SYSTEM$198,927
- MACI$79,765
- EZSTART$79,476
- KNEE BIOLOGICS$55,419
- DONJOY$53,195
- BioBrace 23mm$37,390
- LINVATEC KNEE PRESERVATION SYSTEM$36,181
- KNEE MANUAL INSTRUMENTS$25,500
- Meniscal Root Repair System$22,939
- LIVATEC KNEE PRESERVATION SYSTEM$22,124
- PROCARE$20,891
- EZSTART SCREW$19,132
- NOVOSTITCH$17,511
- NOVOSTITCH PRO$14,384
- MISHA KNEE SYSTEM, SMALL, LEFT$13,800
- ULTRABUTTON$13,371
- Accu-pass$11,715
- Regeneten$10,566
- TRUNAV$10,556
- Zilretta$10,125
How this compares
$1,148,203 in reported general payments places this provider in the 95th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other sports medicine in Stanford
- Michael FreehillStanford$1.6M
- Joseph DonahueStanford$363K
- Tianyi Tim WangStanford$141K
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Stephan YacoubianBurbank$1M
- Stephen Snydervan Nuys$922K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.